These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 15985016)

  • 21. Sequencing of human-viral DNA junctions in hepatocellular carcinoma from patients with HCV and occult HBV infection.
    Tamori A; Nishiguchi S; Kubo S; Enomoto M; Koh N; Takeda T; Shiomi S; Hirohashi K; Kinoshita H; Otani S
    J Med Virol; 2003 Apr; 69(4):475-81. PubMed ID: 12601754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequent detection of hepatitis B virus DNA in hepatocellular carcinoma of patients with sustained virologic response for hepatitis C virus.
    Tamori A; Hayashi T; Shinzaki M; Kobayashi S; Iwai S; Enomoto M; Morikawa H; Sakaguchi H; Shiomi S; Takemura S; Kubo S; Kawada N
    J Med Virol; 2009 Jun; 81(6):1009-14. PubMed ID: 19382258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
    Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virologic analysis of non-B, non-C hepatocellular carcinoma in Japan: frequent involvement of hepatitis B virus.
    Yotsuyanagi H; Shintani Y; Moriya K; Fujie H; Tsutsumi T; Kato T; Nishioka K; Takayama T; Makuuchi M; Iino S; Kimura S; Koike K
    J Infect Dis; 2000 Jun; 181(6):1920-8. PubMed ID: 10837171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SEN virus infection influences the pathological findings in liver but does not affect the incidence of hepatocellular carcinoma in patients with chronic hepatitis C and liver cirrhosis.
    Moriyama M; Mikuni M; Matsumura H; Nakamura H; Oshiro S; Aoki H; Shimizu T; Yamagami H; Shioda A; Kaneko M; Tanaka N; Arakawa Y
    Liver Int; 2005 Apr; 25(2):226-35. PubMed ID: 15780043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Low prevalence of ant-hepatitis c virus antibodies in hepatocellular carcinoma in Senegal].
    Ka MM; Herve P; Leguenno B; Ndiaye MF; Diop TM; Diop B; Dangou JM; Bao O; Brechot C
    Ann Gastroenterol Hepatol (Paris); 1996; 31(6):329-32. PubMed ID: 8920074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occult hepatitis B virus infection in Greek patients with chronic hepatitis C and in patients with diverse nonviral hepatic diseases.
    Georgiadou SP; Zachou K; Rigopoulou E; Liaskos C; Mina P; Gerovasilis F; Makri E; Dalekos GN
    J Viral Hepat; 2004 Jul; 11(4):358-65. PubMed ID: 15230859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
    Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
    Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
    Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
    Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation between markers for viral hepatitis and clinical features of Japanese patients with hepatocellular carcinoma: possible role of alcohol in promoting carcinogenesis.
    Matsuda Y; Amuro Y; Higashino K; Hada T; Yamamoto T; Fujikura M; Yamaguchi K; Shimomura S; Iijima H; Nakano T
    Hepatogastroenterology; 1995 Apr; 42(2):151-4. PubMed ID: 7545640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of SEN virus on immunoblot INNO-LIA HCV reactivity pattern and disease outcome in Egyptian hepatocellular carcinoma patients.
    Alam El-Din HM; Abo-Shadi MA; Helal A
    Egypt J Immunol; 2007; 14(1):1-10. PubMed ID: 18689276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of hepatitis B, hepatitis C, GB virus C/hepatitis G and TT viruses in predialysis and hemodialysis patients.
    López-Alcorocho JM; Barril G; Ortiz-Movilla N; Traver JA; Bartolomé J; Sanz P; Selgas R; Carreño V
    J Med Virol; 2001 Feb; 63(2):103-7. PubMed ID: 11170045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Partial analysis of hepatitis B virus DNA from hepatocellular carcinoma showing negative hepatitis B virus surface antigen: an analysis of two Japanese cases.
    Shiota G; Oyama K; Udagawa A; Nomi T; Tanaka K; Tsutsumi A; Noguchi N; Okano J; Kishimoto Y; Kanbe T; Kishimoto H; Kawasaki H
    Hepatogastroenterology; 2009; 56(94-95):1516-20. PubMed ID: 19950820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hepatitis B virus DNA detection by means of polymerase chain reaction in patients with chronic hepatitis and hepatocellular carcinoma].
    Song Y; Pan W; Fan Z; Du P; Qi Z
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):220-2. PubMed ID: 15617333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan.
    Khan A; Kurbanov F; Tanaka Y; Elkady A; Sugiyama M; Dustov A; Mizokami M
    J Med Virol; 2008 Feb; 80(2):268-76. PubMed ID: 18098133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection.
    Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Bartolomé J; Pardo M; Carreño V
    J Med Virol; 2007 Mar; 79(3):236-41. PubMed ID: 17245725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HBV, HCV, and TTV detection by in situ polymerase chain reaction could reveal occult infection in hepatocellular carcinoma: comparison with blood markers.
    Comar M; Dal Molin G; D'Agaro P; Crocè SL; Tiribelli C; Campello C
    J Clin Pathol; 2006 May; 59(5):526-9. PubMed ID: 16537674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocellular carcinoma and infections with multiple hepatitis viruses.
    Brunetto MR; Oliveri F; Colombatto P; Bonino F
    Princess Takamatsu Symp; 1995; 25():61-6. PubMed ID: 8875610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The significance of hepatitis B virus DNA detected in hepatocellular carcinoma of patients with hepatitis C.
    Shintani Y; Yotsuyanagi H; Moriya K; Fujie H; Tsutsumi T; Takayama T; Makuuchi M; Kimura S; Koike K
    Cancer; 2000 Jun; 88(11):2478-86. PubMed ID: 10861423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.